The aim of this study is to clarify the efficacy of the endovascular treatment for acute ischemic stroke patients with large vessel occlusion and are not respond to intravenous recombinant tissue plasminogen activator (rt-PA) therapy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
19
endovascular treatment using any devises for acute ischemic stroke patients with large vessel occlusion and not respond to intravenous recombinant tissue plasminogen activator (rt-PA) therapy
Hyogo College of Medicine
Nishinomiya, Hyōgo, Japan
Assessment of modified Rankin Scale shift analysis at 90 days after onset
Time frame: 90 days
The rate of mRS 0-2 at 90 days (+/- 10 days) after onset
Time frame: 90 days
Death within 90 days (+/- 10 days) after onset
Time frame: 90 days
Revascularization rates of the target vessel at 72 hours (+/- 8 hours) after onset
for CT angiography or MR angiography
Time frame: 72 hours
Symptomatic intracranial hemorrhage within 72 hours (+/- 8 hours) after onset
Time frame: 72 hours
The difference of NIHSS score between pre-treatment and at 72 hours (+/- 8 hours) after onset
Time frame: 72 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.